An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
Pedestrians wearing protective face masks, amid the coronavirus disease pandemic, walk at a shopping district on the first day after the lifting of COVID-19 restrictions imposed on Tokyo and 17 other prefectures, in Tokyo, Japan, March 22, 2022. REUTERS/Kim Kyung-Hoonhas shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
The company has global aspirations for the antiviral pill, which is now being evaluated by Japanese regulators.The findings released on Sunday also showed "there was no significant difference in total score of 12 COVID-19 symptoms between treatment arms" although the drug showed improvement in a composite score of five "respiratory and feverish" symptoms, Shionogi said.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
UK patient had COVID-19 for 505 days straight, study showsScientists say a U.K. patient with a severely weakened immune system had COVID-19 for almost a year and a half.
Baca lebih lajut »
UK patient had COVID-19 for 505 days straight, study showsAlthough persistent infections are rare, experts said there are many people with compromised immune systems who remain at risk of severe COVID-19. FOX13
Baca lebih lajut »
How to reduce risk of COVID-19 while traveling in a mask-optional world: CDC doctorA judge's order this week voided the mask mandate for those on public transportation.
Baca lebih lajut »
21 people charged with $150M in COVID-19 fraud, DOJ reportsThe Justice Department announced Wednesday that 21 people have been charged in the past nine days as part of a nationwide enforcement push to root out those who exploit the pandemic through health care fraud schemes. FOX13
Baca lebih lajut »
Coachella music festival returns after 2-year hiatus because of COVID-19Its return is a token of our re-emergence from the depths of a pandemic that kept these concert-goers away for three years.
Baca lebih lajut »